KARBE FRANK 4
4 · Cidara Therapeutics, Inc. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
KARBE FRANK
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-12-10$219.60/sh−7,290$1,600,884→ 50,562 total
Footnotes (2)
- [F1]Shares withheld for taxes on RSU vesting.
- [F2]Includes 352 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on November 20, 2025.